metasource: re3data.org version: re3data.org: Coronavirus Antiviral Research Database; editing status 2021-10-05; re3data.org - Registry of Research Data Repositories. http://doi.org/10.17616/R31NJMR6 last accessed: 2022-11-04
metasource: re3data.org version: re3data.org: Coronavirus Antiviral Research Database; editing status 2021-10-05; re3data.org - Registry of Research Data Repositories. http://doi.org/10.17616/R31NJMR6 last accessed: 2022-11-04
metasource: re3data.org version: re3data.org: Coronavirus Antiviral Research Database; editing status 2021-10-05; re3data.org - Registry of Research Data Repositories. http://doi.org/10.17616/R31NJMR6 last accessed: 2022-11-04
metasource: re3data.org version: re3data.org: Coronavirus Antiviral Research Database; editing status 2021-10-05; re3data.org - Registry of Research Data Repositories. http://doi.org/10.17616/R31NJMR6 last accessed: 2022-11-04
The Coronavirus Antiviral Research Database is designed to expedite the development of SARS-CoV-2 antiviral therapy. It will benefit global coronavirus drug development efforts by (1) promoting uniform reporting of experimental results to facilitate comparisons between different candidate antiviral compounds; (2) identifying gaps in coronavirus antiviral drug development research; (3) helping scientists, clinical investigators, public health officials, and funding agencies prioritize the most promising compounds and repurposed drugs for further development; (4) providing an objective, evidenced-based, source of information for the public; and (5) creating a hub for the exchange of ideas among coronavirus researchers whose feedback is sought and welcomed. By comprehensively reviewing all published laboratory, animal model, and clinical data on potential coronavirus therapies, the Database makes it unlikely that promising treatment approaches will be overlooked. In addition, by making it possible to compare the underlying data associated with competing treatment strategies, stakeholders will be better positioned to prioritize the most promising anti-coronavirus compounds for further development.
metasource: re3data.org version: re3data.org: Coronavirus Antiviral Research Database; editing status 2021-10-05; re3data.org - Registry of Research Data Repositories. http://doi.org/10.17616/R31NJMR6 last accessed: 2022-11-04
CoVdb is a database resource for Genome-wide dynamics analysis of Coronaviruses on a historical and global scale.
metasource: re3data.org version: re3data.org: Coronavirus Antiviral Research Database; editing status 2021-10-05; re3data.org - Registry of Research Data Repositories. http://doi.org/10.17616/R31NJMR6 last accessed: 2022-11-04
metasource: re3data.org version: re3data.org: Coronavirus Antiviral Research Database; editing status 2021-10-05; re3data.org - Registry of Research Data Repositories. http://doi.org/10.17616/R31NJMR6 last accessed: 2022-11-04
metasource: re3data.org version: re3data.org: Coronavirus Antiviral Research Database; editing status 2021-10-05; re3data.org - Registry of Research Data Repositories. http://doi.org/10.17616/R31NJMR6 last accessed: 2022-11-04
Publications:
Publications
More detailed information about this field from each metasource.
metasource: re3data.org version: re3data.org: Coronavirus Antiviral Research Database; editing status 2021-10-05; re3data.org - Registry of Research Data Repositories. http://doi.org/10.17616/R31NJMR6 last accessed: 2022-11-04
metasource: re3data.org version: re3data.org: Coronavirus Antiviral Research Database; editing status 2021-10-05; re3data.org - Registry of Research Data Repositories. http://doi.org/10.17616/R31NJMR6 last accessed: 2022-11-04
additional host-targeting compounds
metasource: re3data.org version: re3data.org: Coronavirus Antiviral Research Database; editing status 2021-10-05; re3data.org - Registry of Research Data Repositories. http://doi.org/10.17616/R31NJMR6 last accessed: 2022-11-04
clinical trials
metasource: re3data.org version: re3data.org: Coronavirus Antiviral Research Database; editing status 2021-10-05; re3data.org - Registry of Research Data Repositories. http://doi.org/10.17616/R31NJMR6 last accessed: 2022-11-04
entry inhibitors
metasource: re3data.org version: re3data.org: Coronavirus Antiviral Research Database; editing status 2021-10-05; re3data.org - Registry of Research Data Repositories. http://doi.org/10.17616/R31NJMR6 last accessed: 2022-11-04
interferons
metasource: re3data.org version: re3data.org: Coronavirus Antiviral Research Database; editing status 2021-10-05; re3data.org - Registry of Research Data Repositories. http://doi.org/10.17616/R31NJMR6 last accessed: 2022-11-04
polymerase inhibitors
metasource: re3data.org version: re3data.org: Coronavirus Antiviral Research Database; editing status 2021-10-05; re3data.org - Registry of Research Data Repositories. http://doi.org/10.17616/R31NJMR6 last accessed: 2022-11-04
protease inhibitors
metasource: re3data.org version: re3data.org: Coronavirus Antiviral Research Database; editing status 2021-10-05; re3data.org - Registry of Research Data Repositories. http://doi.org/10.17616/R31NJMR6 last accessed: 2022-11-04
virology
metasource: re3data.org version: re3data.org: Coronavirus Antiviral Research Database; editing status 2021-10-05; re3data.org - Registry of Research Data Repositories. http://doi.org/10.17616/R31NJMR6 last accessed: 2022-11-04